OSRH

OSR Health, Inc.

NasdaqCMUSDEQUITY DELAYED

0.27

▼ 0.02 (6.95%)

MARKET · —

Price

Open

0.27

Prev close

0.29

Day high

0.33

Day low

0.27

Volume

4.82M

Market cap

—

P/E (TTM)

—

52W range

0.25 – 1.24

Trailing performance

Price return · vs SPY

Returnvs SPY

-12.34% -11.0%

-38.44% -42.2%

-45.69% -48.8%

-33.25% -44.3%

YTD

-50.89% -63.2%

-44.71% -64.7%

-97.32% -171.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

0.37

-24.82% from price

SMA 20

0.41

-31.77% from price

SMA 50

0.39

-28.43% from price

SMA 100

0.46

-40.80% from price

SMA 200

0.52

-46.38% from price

EMA 12

0.37

-26.26% from price

EMA 26

0.39

-29.92% from price

EMA 50

0.41

-32.71% from price

RSI (14)

41.1

Neutral

MACD (12,26,9)

-0.02

Hist -0.01

ATR (14)

0.12

43.50% of price

Realised vol 30D

251.5%

Annualised

Bollinger upper

0.56

20, 2σ

Bollinger lower

0.25

20, 2σ

50 / 200 cross

Death

0.39 vs 0.52

Trend bias

Below 200

-46.38%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.29

More volatile than market

Correlation to SPY

0.09

Largely independent

Realised vol 30D

251.5%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-72.6%

Peak to trough

Max drawdown 5Y

-97.7%

Peak to trough

ATR 14

0.12

43.50% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 0.27

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

OSRH · links out to the publisher

OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission ACCESS Newswire · 1d ago Sector Update: Healthcare Stocks Fall Thursday Afternoon MT Newswires · 2d ago Top Premarket Decliners MT Newswires · 2d ago OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal ACCESS Newswire · 3d ago OSR Health Sees Global Shareholder Momentum at Critical Inflection Point ACCESS Newswire · 3d ago BC-Most Active Stocks Associated Press · 4d ago OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development ACCESS Newswire · 11d ago OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program ACCESS Newswire · 15d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.